| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269549 | HPB | 2010 | 6 Pages |
Abstract
Five-year survival rates are not adequate to evaluate surgical outcomes of patients with CLM. Approximately one-third of actual 5-year survivors suffer cancer-related death, whereas patients who survive 10 years appear to be cured of disease.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Carlo Pulitanò, Federico Castillo, Luca Aldrighetti, Martin Bodingbauer, Rowan W. Parks, Gianfranco Ferla, Stephen J. Wigmore, O. James Garden,